10.07.26 -- Investigator Responsibilities In Decentralized Clinical Trials

Inconsistent ocular data and slow visits often trace back to the exam room. Before finalizing site plans, learn what equipment, layout, and staffing a properly built space requires.

Obesity is a hot topic in the pharmaceutical industry, with GLP-1 drugs dominating the headlines. Globally, there are 5,189 obesity trials, of which 1,119 are planned or ongoing.

Experience a live mock IRB review! Watch industry experts evaluate a fictional protocol to uncover insights into board decision-making, master the review process, and improve your future submissions.

Managing CRS and immune risks demands early detection, rapid response, and skilled teams. Strong infrastructure and clear protocols enable safer immunotherapy trials beyond academic centers.

Optimize dose selection in oncology trials by moving beyond toxicity limits. Use advanced modeling and benefit-risk analysis to improve efficacy and meet modern regulatory standards.

Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.

Gain visibility, flexible supply management, and real-time decision support to reduce waste, control costs, and align supply with evolving trial needs.

As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before.

See how parallel processing integrates clinical supply into drug development, enabling simultaneous workstreams that address packaging, labeling, and sourcing challenges.